» Articles » PMID: 36637031

Survival, Remission, and Quality of Life in Diabetic Cats

Overview
Date 2023 Jan 13
PMID 36637031
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Remission is documented in a substantial proportion of cats with diabetes. The effects of diabetes mellitus (DM) on the lives of cats and their owners should be considered when evaluating treatment success.

Objectives: To study outcome in cats with DM and the impact DM has on the life situation of cat and owner.

Animals: Domestic and pedigree cats with a diagnosis of DM (n = 477) insured by a Swedish insurance company during 2009 to 2013.

Methods: Retrospective cross-sectional study. A questionnaire was sent to 1369 owners of cats diagnosed with DM. The questions concerned the cat, treatment, owner perceptions of the disease and treatment and disease outcome. Data were analyzed using multiple linear and logistic regression, with outcomes set as survival for more than 4 weeks after diagnosis, survival time, achieving remission, remission without relapse and quality of life (QoL) for the cat.

Results: The response rate was 35%, leaving 477 questionnaires for analysis. The remission rate among treated cats was 29% (118/405). Feeding a commercially available wet diet was associated with both remission (OR 3.16, 95% confidence interval 1.27-8.12) and remission without relapse (OR 14.8, 95% confidence interval 2.25-153.8). Remission was associated with a better QoL for the cat.

Conclusions And Clinical Importance: The association between feeding a commercially available wet diet and remission is important and strengthens the role of diet in treatment of DM in cats. Linking remission and a better QoL for the cat emphasizes remission as a goal in disease management.

Citing Articles

SGLT2 inhibitor use in the management of feline diabetes mellitus.

Cook A, Behrend E J Vet Pharmacol Ther. 2024; 48 Suppl 1():19-30.

PMID: 38954371 PMC: 11736986. DOI: 10.1111/jvp.13466.


Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.

Gottlieb S, Rand J, Anderson S J Feline Med Surg. 2024; 26(4):1098612X241232546.

PMID: 38661475 PMC: 11103314. DOI: 10.1177/1098612X241232546.


Survival, remission, and quality of life in diabetic cats.

Rothlin-Zachrisson N, Ohlund M, Rocklinsberg H, Holst B J Vet Intern Med. 2023; 37(1):58-69.

PMID: 36637031 PMC: 9889602. DOI: 10.1111/jvim.16625.

References
1.
Niessen S, Forcada Y, Mantis P, Lamb C, Harrington N, Fowkes R . Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter. PLoS One. 2015; 10(5):e0127794. PMC: 4449218. DOI: 10.1371/journal.pone.0127794. View

2.
Niessen S, Hazuchova K, Powney S, Guitian J, Niessen A, Pion P . The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia. Vet Sci. 2017; 4(2). PMC: 5606606. DOI: 10.3390/vetsci4020027. View

3.
Niessen S, Bjornvad C, Church D, Davison L, Esteban-Saltiveri D, Fleeman L . Agreeing Language in Veterinary Endocrinology (ALIVE): Diabetes mellitus - a modified Delphi-method-based system to create consensus disease definitions. Vet J. 2022; 289:105910. DOI: 10.1016/j.tvjl.2022.105910. View

4.
Roomp K, Rand J . Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control. J Feline Med Surg. 2012; 14(8):566-72. PMC: 11104196. DOI: 10.1177/1098612X12446211. View

5.
Bijsmans E, Jepson R, Syme H, Elliott J, Niessen S . Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease. J Vet Intern Med. 2015; 30(1):183-91. PMC: 4913638. DOI: 10.1111/jvim.13656. View